HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.

Abstract
We have used antisense phosphorothioate oligonucleotides to define the role played by proliferating cell nuclear antigen (PCNA) in neointimal accumulation of smooth muscle cells in a rat carotid artery injury model. The short-term extraluminal delivery of 250 nmol of antisense oligonucleotides, but not control oligonucleotides, immediately after arterial injury produces a 77% suppression of PCNA mRNA after 24 h and a 52% decrease in the frequency of medial smooth muscle cells expressing PCNA after 72 h. This reduction in PCNA expression is accompanied by a 59% decrease in the frequency of proliferating medial smooth muscle cells at 3 d as measured by BudR staining and an 80% decrease in neointimal accumulation assessed morphometrically at 2 wk. Thus, the expression of PCNA is required for medial smooth muscle cell growth in vivo and for neointimal formation after arterial injury.
AuthorsM Simons, E R Edelman, R D Rosenberg
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 93 Issue 6 Pg. 2351-6 (Jun 1994) ISSN: 0021-9738 [Print] United States
PMID7911126 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Nuclear Proteins
  • Oligonucleotides, Antisense
  • Proliferating Cell Nuclear Antigen
Topics
  • Animals
  • Base Sequence
  • Carotid Arteries (pathology)
  • Cell Division
  • Cell Line
  • Hyperplasia
  • Molecular Sequence Data
  • Muscle, Smooth, Vascular (pathology)
  • Nuclear Proteins (analysis, physiology)
  • Oligonucleotides, Antisense (pharmacology)
  • Proliferating Cell Nuclear Antigen
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: